MedTrace Logo

Trial of Stimulus-response Potentiation in Schizophrenia

NCT03892876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-07-01

No results posted yet for this study

Summary

This clinical trial aims at examining the effects of auditory high-frequency stimulation in schizophrenia patient, aiming to increase their AEPs, which are known to be attenuated from previous literature

Conditions

Interventions

DIAGNOSTIC_TEST

Auditory High Frequency Tetanizing Stimulation

50 ms tone pips presented at high frequency for 120 seconds

DIAGNOSTIC_TEST

Sham Comparator

auditory tone pips with interstimulus interval (ISI) 1 sec

Sponsors & Collaborators

  • University of Pittsburgh

    collaborator OTHER

  • Cairo University

    lead OTHER

Principal Investigators

  • Ola O Shahin, MD · Department of Psychiatry-University of Cairo

  • Vishwajit L Nimgaonkar, PhD · Department of Psychiatry-University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-04-15
Completion
2021-04-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03892876 on ClinicalTrials.gov